SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drugs - Quaterly Results

13 Aug 2025 Evaluate
A decrease in the sales to Rs. 238.11 millions was observed for the quarter ended June 2025. The sales stood at Rs. 322.08 millions during the similar quarter previous year.Net profit of the cmpany stood at Rs. 10.41 millions for the quarter ended June 2025 a decline of -36.21% from Rs. 16.32 millions  in the same quarter last year.Operating Profit reported a sharp decline to 29.12 millions from 39.98 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 238.11 322.08 -26.07 238.11 322.08 -26.07 1133.50 1567.12 -27.67
Other Income 0.12 7.65 -98.43 0.12 7.65 -98.43 9.77 6.18 58.09
PBIDT 29.12 39.98 -27.16 29.12 39.98 -27.16 128.04 139.22 -8.03
Interest 10.05 14.35 -29.97 10.05 14.35 -29.97 47.32 49.15 -3.72
PBDT 19.07 25.63 -25.60 19.07 25.63 -25.60 80.72 89.17 -9.48
Depreciation 6.04 5.50 9.82 6.04 5.50 9.82 24.48 19.95 22.71
PBT 13.03 20.13 -35.27 13.03 20.13 -35.27 56.24 69.22 -18.75
TAX 2.62 3.81 -31.23 2.62 3.81 -31.23 12.45 13.73 -9.32
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 10.41 16.32 -36.21 10.41 16.32 -36.21 43.79 55.49 -21.08
Equity 75.30 75.30 0.00 75.30 75.30 0.00 75.30 75.30 0.00
PBIDTM(%) 12.23 12.41 -1.48 12.23 12.41 -1.48 11.30 8.88 27.15

Godavari Drugs Share Price

124.95 -0.85 (-0.68%)
05-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.75
Dr. Reddys Lab 1270.95
Cipla 1333.55
Zydus Lifesciences 911.85
Lupin 2343.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×